StockData

SBC Medical vs Starling Oncology

SBC and STLN side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How SBC and STLN compare

SBC Medical is the larger company, worth 1.8 times as much as Starling Oncology ($629M against $347M).

Starling Oncology grew revenue faster over the last twelve months (34.6% versus −6.9% for SBC Medical).

SBC Medical keeps more of each dollar of sales as profit, with a net margin of 28.0% compared with −5.7% at Starling Oncology.

SBC Medical scores higher on the StockData Score (12 against 7 for Starling Oncology), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricSBCSTLN
Size and price
Market cap$629M$347M
Share price$6.12$3.40
Change, 1 year84.9%−14.4%
Change, 5 years–−49.3%
Beta (5Y)1.212.39
Employees863641
StockData Score
Total score12 (better)7
Valuation score4 (better)1
Growth score03 (better)
Performance score3 (better)1
Health score5 (better)2
Dividend score00
Valuation
P/E13.0×–
P/S3.6×0.6× (better)
P/B2.4×–
EV/EBITDA6.7×–
P/FCF10.2× (better)18.4×
FCF yield9.8% (better)5.4%
Fair value$9.32–
Margin of safety34.3%–
Growth
Revenue growth (TTM)−6.9%34.6% (better)
Revenue growth, 5Y average–21.8%
Net income growth (TTM)47.1%–
EPS growth (TTM)46.9%–
Profitability
Gross margin71.9%–
Operating margin37.3% (better)−3.4%
Net margin28.0% (better)−5.7%
FCF margin35.3% (better)3.0%
Return on equity19.3%–
Return on invested capital50.7% (better)−96.2%
Financial health
Debt / equity0.00–
Net debt / EBITDA−2.69–
Interest coverage195× (better)−2.0×
Current ratio3.31 (better)1.11
Altman Z-score5.38 (better)1.72
Piotroski F-score4 (better)3
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions8.3%43.4%
Held by insiders82.0%56.6%
Insider net buying, 12 months−$20.1M−$11.1M (better)

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.